← Back to headlines
Gossamer Bio's Lung Condition Drug Fails Late-Stage Trial
Gossamer Bio's experimental drug for a lung condition has reportedly failed in its late-stage clinical trial, impacting the company's prospects.
23 Feb, 13:08 — 23 Feb, 13:08
ℹOnly 1 source covers this story
